drugset
drugset / Trial / NCT00434395

Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

NCT00434395 ↗

Phase 1 Completed Bausch Health Americas, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.

Timeline

Start
2007-03
Primary completion
—
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified — Intravenous

Indications

No indication recorded.